SCHEMBL18930487

SCHEMBL18930487

N=Cc1ccc(Br)cc1NCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ HTT P42858 1/20 0.50
▸ HPGD P15428 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ PDE5A O76074 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CCNC P24863 1/20 0.41
▸ CDK8 P49336 1/20 0.41
▸ KMT2A Q03164 1/20 0.39
▸ GAA P10253 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ APP P05067 3/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38
▸ PTPN1 P18031 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19382047 0.80 HDAC8 (0.41) SMN1; SMN2HTTHPGDHSD17B10KDM4E
SCHEMBL18930965 0.80 HSD17B10 (0.53) HTTHPGDHSD17B10KDM4ETSHR
SCHEMBL18930822 0.79 HSD17B10 (0.40) LMNAHTTHPGDHSD17B10KDM4E
SCHEMBL13362102 0.78 HTT (0.57) SMN1; SMN2LMNAHTTHPGDHSD17B10
SCHEMBL27408729 0.78 TDP1 (0.42) HPGDHSD17B10KDM4ETSHRKMT2A
SCHEMBL23505931 0.77 HPGD (0.39) SMN1; SMN2LMNAHTTHPGDKDM4E
SCHEMBL12684764 0.76 HDAC1 (0.60) SMN1; SMN2LMNAHTTHPGDHSD17B10
SCHEMBL10873524 0.76 IDO1 (0.56) SMN1; SMN2LMNAHTTHPGDHSD17B10
SCHEMBL15854548 0.76 HDAC8 (0.60) SMN1; SMN2LMNAHTTHPGDHSD17B10
SCHEMBL1519151 0.76 SMN1; SMN2 (0.47) SMN1; SMN2LMNAHTTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024076891-A1 POLO LIKE KINASE 4 INHIBITORS ORIC PHARMACEUTICALS, INC. (US) 2024-04-11 — — WO disclosed
EP-2556070-B1 SYNTHESIS OF CHIRAL 2-(1H-INDAZOL-6-YL)-SPIRO[CYCLOPROPANE-1,3'- INDOLIN]-2'-ONES UNIV HEALTH NETWORK (CA) 2017-06-07 — — EP disclosed
Send feedback